Exosomes and Nanoengineering: A Match Made for Precision Therapeutics

Adv Mater. 2020 May;32(18):e1904040. doi: 10.1002/adma.201904040. Epub 2019 Sep 18.

Abstract

Targeted exosomal delivery systems for precision nanomedicine attract wide interest across areas of molecular cell biology, pharmaceutical sciences, and nanoengineering. Exosomes are naturally derived 50-150 nm nanovesicles that play important roles in cell-to-cell and/or cell-to-tissue communications and cross-species communication. Exosomes are also a promising class of novel drug delivery vehicles owing to their ability to shield their payload from chemical and enzymatic degradations as well as to evade recognition by and subsequent removal by the immune system. Combined with a new class of affinity ligands known as aptamers or chemical antibodies, molecularly targeted exosomes are poised to become the next generation of smartly engineered nanovesicles for precision medicine. Here, recent advances in targeted exosomal delivery systems engineered by aptamer for future strategies to promote human health using this class of human-derived nanovesicles are summarized.

Keywords: aptamers; exosomes; nanoengineering; precision therapeutics; targeting ligands.

Publication types

  • Review

MeSH terms

  • Animals
  • Engineering*
  • Exosomes*
  • Humans
  • Nanomedicine / methods*
  • Precision Medicine / methods*